참고문헌
- Rahmani R, Sukumaran M, Donaldson AM, Akselrod O, Lavi E, Schwartz TH. Parasellar xanthogranulomas. J Neurosurg 2015;122:812-7. https://doi.org/10.3171/2014.12.JNS14542
- Liu ZH, Tzaan WC, Wu YY, Chen HC. Sellar xanthogranuloma manifesting as obstructive hydrocephalus. J Clin Neurosci 2008;15:929-33. https://doi.org/10.1016/j.jocn.2007.05.028
- Kamoshima Y, Sawamura Y, Motegi H, Kubota K, Houkin K. Xanthogranuloma of the sellar region of children: series of five cases and literature review. Neurol Med Chir (Tokyo) 2011;51:689-93. https://doi.org/10.2176/nmc.51.689
- Nishiuchi T, Murao K, Imachi H, et al. Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report. J Med Case Rep 2012;6:119. https://doi.org/10.1186/1752-1947-6-119
- Hernandez-Estrada RA, Kshettry VR, Vogel AN, Curtis MT, Evans JJ. Cholesterol granulomas presenting as sellar masses: a similar, but clinically distinct entity from craniopharyngioma and Rathke's cleft cyst. Pituitary 2017;20:325-32. https://doi.org/10.1007/s11102-016-0775-5
- Yang B, Yang C, Fang J, et al. Clinicoradiologic features and surgical outcomes of sellar xanthogranulomas: a single-center 10-year experience. World Neurosurg 2017;99:439-47. https://doi.org/10.1016/j.wneu.2016.12.017
- Dai CX, Guo XS, Liu XH, et al. Xanthogranuloma of the sellar region. Chin Med J (Engl) 2017;130:249-50.
- Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 1999;97:377-82. https://doi.org/10.1007/s004010051001
- Amano K, Kubo O, Komori T, et al. Clinicopathological features of sellar region xanthogranuloma: correlation with Rathke's cleft cyst. Brain Tumor Pathol 2013;30:233-41. https://doi.org/10.1007/s10014-012-0130-0
- Miyajima Y, Oka H, Utsuki S, Fujii K. Rathke's cleft cyst with xanthogranulomatous change--case report. Neurol Med Chir (Tokyo) 2011;51:740-2. https://doi.org/10.2176/nmc.51.740
- Hama S, Arita K, Nishisaka T, et al. Changes in the epithelium of Rathke cleft cyst associated with inflammation. J Neurosurg 2002;96:209-16. https://doi.org/10.3171/jns.2002.96.2.0209
- Le BH, Towfighi J, Kapadia SB, Lopes MB. Comparative immunohistochemical assessment of craniopharyngioma and related lesions. Endocr Pathol 2007;18:23-30. https://doi.org/10.1007/s12022-007-0011-y
- Arai A, Nishihara M, Sasayama T, et al. Xanthogranuloma of the sellar region--case report. Neurol Med Chir (Tokyo) 2010;50:488-91. https://doi.org/10.2176/nmc.50.488
- Jung CS, Schanzer A, Hattingen E, Plate KH, Seifert V. Xanthogranuloma of the sellar region. Acta Neurochir (Wien) 2006;148:473-7. https://doi.org/10.1007/s00701-005-0700-6
- Sugata S, Hirano H, Yatsushiro K, Yunoue S, Nakamura K, Arita K. Xanthogranuloma in the suprasellar region. Neurol Med Chir (Tokyo) 2009;49:124-7. https://doi.org/10.2176/nmc.49.124
- Hofmann BM, Kreutzer J, Saeger W, et al. Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006;30:1595-603. https://doi.org/10.1097/01.pas.0000213328.64121.12
- Buslei R, Nolde M, Hofmann B, et al. Common mutations of betacatenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005;109:589-97. https://doi.org/10.1007/s00401-005-1004-x